Filing Details
- Accession Number:
- 0001209191-16-149216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-10 07:15:42
- Reporting Period:
- 2016-11-09
- Filing Date:
- 2016-11-10
- Accepted Time:
- 2016-11-10 07:15:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1460329 | Cogint Inc. | COGT | Services-Advertising (7310) | 770688094 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1660879 | Matthew Conlin | C/O Cogint, Inc. 2650 North Military Trail, Suite 300 Boca Raton FL 33431 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-11-09 | 5,000 | $3.73 | 5,352,062 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 550,000 | Direct | |
Common Stock | 2,000,000 | Indirect | Held by RSMC Partners, LLC of which the reporting person is a member. |
Common Stock | 20,000 | Indirect | Held by Conlin Family Foundation Trust in which the Reporting Person serves as co-trustee. |
Footnotes
- The shares were purchased in multiple transactions at prices ranging from $3.70 to $3.85, with a weighted average price per share of $3.73. The reporting person undertakes to provide Cogint, Inc., any security holder of Cogint, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote.
- On December 8, 2015, the reporting person received a grant, subject to stockholder approval, of 550,000 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis. Stockholder approval was obtained on June 1, 2016. The RSUs are subject to vesting over a three-year period of 30% on January 1, 2017, 30% on January 1, 2018 and 40% on January 1, 2019 (the "Time Conditions") provided, however, that no tranche of RSUs will vest until it is determined that IDI has exceeded certain revenue targets and achieved positive EBITDA in any one fiscal year during the vesting period (the "Performance Conditions"). Upon a determination that IDI has exceeded the Performance Conditions, any RSUs that would have otherwise vested in accordance with the Time Conditions will vest at the time of such determination. Any subsequent tranches will vest in accordance with the Time Conditions.
- The RSUs will immediately vest upon (i) a Change of Control, or (ii) the reporting person's death or disability.